Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $92.09 USD
Change Today -1.89 / -2.01%
Volume 14.6M
JNJ On Other Exchanges
New York
Sao Paulo
As of 8:04 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alex Gorsky

Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee,Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 40 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Alex Gorsky has been the Chairman and Chief Executive Officer of Johnson & Johnson since December 28, 2012 and April 26, 2012 respectively. Mr. Gorsky served as the Chief Operating Officer and Head of General Medicines at Novartis Pharmaceuticals Corporation from May 2004 to February 2008. He also served as the Chief Executive Officer of Novartis Pharmaceuticals from 2005 to February 2008 and as its Head of Pharma North America since 2005. He was responsible for ...

Read Full Background

Corporate Headquarters*

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships*

Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Director and Member of Executive Compensation & Management Resources Committee


MBA 1996
University of Pennsylvania - The Wharton School
BS 1982
United States Military Academy

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$9,467,380
All Other Compensation$228,866
Exercisable Options264,465
Exercisable Options Value$11,284,667
Unexercisable Options1,274,789
Unexercisable Options Value$34,256,114
Total Value of Options$45,540,780
Total Number of Options1,539,254

Total Compensation*

Total Annual Cash Compensation$6,747,645
Total Short Term Compensation$1,500,000
Other Long Term Compensation$9,696,246
Total Calculated Compensation$24,989,306
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $92.09 USD -1.89


Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at